Open Access
Issue
Vet. Res.
Volume 41, Number 3, May–June 2010
Number of page(s) 13
DOI http://dx.doi.org/10.1051/vetres/2010002
Published online 13 January 2010
How to cite this article Vet. Res. (2010) 41:30
  • Bachrach H.L., Foot-and-mouth disease virus, Annu. Rev. Microbiol. (1968) 22:201–244. [CrossRef] [PubMed]
  • Barnett P.V., Carabin H., A review of emergency foot-and-mouth disease (FMD) vaccines, Vaccine (2002) 20:1505–1514. [CrossRef] [PubMed]
  • Bitko V., Musiyenko A., Shulyayeva O., Barik S., Inhibition of respiratory viruses by nasally administered siRNA, Nat. Med. (2005) 11:50–55. [CrossRef] [PubMed]
  • Brown C.C., Piccone M.E., Mason P.W., McKenna T.S.-C., Grubman M.J., Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle, J. Virol. (1996) 70:5638–5641. [PubMed]
  • Chen W., Yan W., Du Q., Fei L., Liu M., Ni Z., , RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice, J. Virol. (2004) 78:6900–6907. [CrossRef] [PubMed]
  • Chen W., Liu M., Jiao Y., Yan W., Wei X., Chen J., , Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo, J. Virol. (2006) 80:3559–3566. [CrossRef] [PubMed]
  • Chenard G., Miedema K., Moonen P., Schrijver R.S., Dekker A., A solid-phase blocking ELISA for detection of type O foot-and-mouth disease virus antibodies suitable for mass serology, J. Virol. Methods (2003) 107:89–98. [CrossRef] [PubMed]
  • Curtiss R.T., Hassan J.O., Herr J., Kelly S.M., Levine M., Mahairas G.G., , Nonrecombinant and recombinant avirulent salmonella vaccine, in: Talwar G.P., Rao K.V.S., Chauhan V.S. (Eds.), Recombinant and synthetic vaccines, Norosa Publishing House, New Delhi, India, 1994, pp. 340–351.
  • Darji A., Guzman C.A., Gerstel B., Wachholz P., Timmis K.N., Wehland J., , Oral somatic transgene vaccination using attenuated S. typhimurium, Cell (1997) 91:765–775. [CrossRef] [PubMed]
  • Darji A., Lage S.Z., Garbe A.I., Chakraborty T., Weiss S., Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier, FEMS Immunol. Med. Microbiol. (2000) 27:341–349. [CrossRef] [PubMed]
  • De los Santos T., Wu Q., de Avila Botton S., Grubman M.J., Short hairpin RNA targeted to the highly conserved 2B nonstructural protein coding region inhibits replication of multiple serotypes of foot-and-mouth disease virus, Virology (2005) 335:222–231. [CrossRef] [PubMed]
  • Dietrich G., Gentschev I., Hess J., Ulmer J.B., Kaufmann S.H.E., Goebel W., Delivery of DNA vaccines by attenuated intracellular bacteria, Trends Immunol. Today (1999) 20:251–253. [CrossRef]
  • Fang X.W., Li Y.L., Huang C.B., Zheng M., Feng W.D., Sun W., Live vaccine against swine paratyphoid from the attenuated smooth strain C500 of Salmonella choleraesuis, Acta Veterinaria Zootechnica Sinica (1981) 12:99–106.
  • Fountaine T.M., Wood M.J.A., Wade-Martins R., Delivering RNA interference to the mammalian brain, Curr. Gene Ther. (2005) 5:399–410. [CrossRef] [PubMed]
  • Geisbert T.W., Hensley L.E., Kagan E., Yu E.Z., Geisbert J.B., Daddario-DiCaprio K., , Post exposure protection of guinea pigs against a lethal Ebola virus challenge is conferred by RNA interference, J. Infect. Dis. (2006) 193:1650–1657. [CrossRef] [PubMed]
  • Gitlin L., Karelsky S., Andino R., Short interfering RNA confers intracellular antiviral immunity in human cells, Nature (2002) 418:430–434. [CrossRef] [PubMed]
  • Gitlin L., Andino R., Nucleic acid-based immune system: the antiviral potential of mammalian RNA silencing, J. Virol. (2003) 77:7159–7165. [CrossRef] [PubMed]
  • Gray J., Fedorka-Cray P., Stabel T., Ackermann M., Influence of inoculation route on the carrier state of Salmonella choleraesuis in swine, Vet. Microbiol. (1995) 47:43–59. [CrossRef] [PubMed]
  • Grubman M.J., Baxt B., Foot-and-mouth disease, Clin. Microbiol. Rev. (2004) 17:465–493. [CrossRef] [PubMed]
  • Grubman M.J., de los Santos T., Rapid control of foot-and-mouth disease outbreaks: is RNAi a possible solution?, Trends Immunol. (2005) 26:65–68. [CrossRef] [PubMed]
  • Hohjoh H., RNA interference (RNA (i)) induction with various types of synthetic oligonucleotide duplexes in cultured human cells, FEBS Lett. (2002) 521:195–199. [CrossRef] [PubMed]
  • Hohjoh H., Enhancement of RNAi activity by improved siRNA duplexes, FEBS Lett. (2004) 557:193–198. [CrossRef] [PubMed]
  • Holen T., Amarzguioui M., Wiiger M.T., Babaie E., Prydz H., Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor, Nucleic Acids Res. (2002) 30:1757–1766. [CrossRef] [PubMed]
  • Kahana R., Kuznetzova L., Rogel A., Shemesh M., Hai D., Yadin H., Stram Y., Inhibition of foot-and-mouth disease virus replication by small interfering RNA, J. Gen. Virol. (2004) 85:3213–3217. [CrossRef] [PubMed]
  • Kim S., Lee K., Park J., Ko Y., Joo Y., Kim H., Park J., Therapeutic application of RNA interference against foot-and-mouth disease virus in vitro and in vivo, Antiviral. Res. (2008) 80:178–184. [CrossRef] [PubMed]
  • King A.M., Underwood B.O., McCahon D., Newman J.W., Brown F., Biochemical identification of viruses causing the 1981 outbreaks of foot-and-mouth disease in the UK, Nature (1981) 293:479–480. [CrossRef] [PubMed]
  • Li B.J., Tang Q., Cheng D., Qin C., Xie F.Y., Wei Q., , Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque, Nat. Med. (2005) 11:944–951. [PubMed]
  • Liu M., Chen W., Ni Z., Yan W., Fei L., Jiao Y., , Cross-inhibition to heterologous foot-and-mouth disease virus infection induced by RNA interference targeting the conserved regions of viral genome, Virology (2005) 336:51–59. [CrossRef] [PubMed]
  • Liu M., Niu X., Yan J., Yan W., Zheng Z., Immure response induced by oral DNA vaccination against FMDV delivered by attenuated Salmonella choleraesuis C500, Front. Biol. China (2006) 2:110–114. [CrossRef]
  • Lu S., Cullen B.R., Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and microRNA biogenesis, J. Virol. (2004) 78:12868–12876. [CrossRef] [PubMed]
  • Mason P.W., Piccone M.E., Mckenna T.S., Chinsangaram J., Grubman M.J., Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate, Virology (1997) 227:96–102. [CrossRef] [PubMed]
  • Mercado R., Vijh S., Allen S.E., Kerksiek K., Pilip I.M., Pamer E.G., Early programming of T cell populations responding to bacterial infection, J. Immunol. (2000) 165:6833–6839. [PubMed]
  • Mohapatra J.K., Sanyal A., Hemadri D., Tosh C., Kumar R.M., Bandyopadhyay S.K., Evaluation of in vitro inhibitory potential of small interfering RNAs directed against various regions of foot-and-mouth disease virus genome, Biochem. Biophys. Res. Commun. (2005) 329:1133–1138. [CrossRef] [PubMed]
  • O’Reilly E.K., Kao C.C., Analysis of RNA-dependent RNA polymerase structure and function as guided by known polymerase structures and computer predictions of secondary structure, Virology (1998) 252:287–303. [CrossRef] [PubMed]
  • Paglia P., Medina E., Arioli I., Guzman C.A., Colombo M.P., Gene transfer in dendritic cells induced by oral DNA vaccination with Salmonella typhimurium results in protective immunity against a murine fibrosarcoma, Blood (1998) 92:3172–3176. [PubMed]
  • Pereira H.G., Foot-and-mouth disease, in: Gibbs E.P.J. (Ed.), Virus diseases of food animals, Academic Press, Inc., San Diego, California, 1981, pp. 333–363.
  • Prato Murphy M.L., Meyer R.F., Mebus C., Schudel A.A., Rodriguez M., Analysis of sites of FMDV persistence in carrier cattle via the polymerase chain reaction, Arch. Virol. (1994) 136:299–307. [CrossRef] [PubMed]
  • Reed L.J., Muench H.A., A simple method of estimating fifty percent end points, Am. J. Hyg. (1938) 27:493–497.
  • Rigden R.C., Carrasco C.P., Barnett P.V., Summerfield A., McCullough K.C., Innate immune responses following emergency vaccination against foot-and-mouth disease virus in pigs, Vaccine (2003) 21:1466–1477. [CrossRef] [PubMed]
  • Shen C., Buck A.K., Liu X., Winkler M., Reske S.N., Gene silencing by adenovirus-delivered siRNA, FEBS Lett. (2003) 539:111–114. [CrossRef] [PubMed]
  • Shiau A.L., Chen Y.L., Liao C.Y., Huang Y.S., Wu C.L., Prothymosin enhances protective immune responses induced by oral DNA vaccination against pseudorabies delivered by Salmonella choleraesuis, Vaccine (2001) 19:3947–3956. [CrossRef] [PubMed]
  • Song E., Lee S.K., Dykxhoorn D.M., Novina C., Zhang D., Crawford K., , Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages, J. Virol. (2003) 77:7174–7181. [CrossRef] [PubMed]
  • Srinivasan A., Foley J., Ravindran R., McSorley S.J., Low-dose Salmonella infection evades activation of flagellin-specific CD4 T cells, J. Immunol. (2004) 173:4091–4099. [PubMed]
  • Steitz T.A., A mechanism for all polymerases, Nature (1998) 391:231–232. [CrossRef] [PubMed]
  • Sun T., Lu P., Wang X., Localization of infection-related epitopes on the nonstructural protein 3ABC of foot-and-mouth disease virus and the application of tandem epitopes, J. Virol. Methods (2004) 119:79–86. [CrossRef] [PubMed]
  • Ter Brake O., Konstantinova P., Ceylan M., Berkhout B., Silencing of HIV-1 with RNA interference: a multiple shRNA approach, Mol. Ther. (2006) 14:883–892. [CrossRef] [PubMed]
  • Woo P., Wong L., Zheng B., Yuen K., Unique immunogenicity of hepatitis B virus DNA vaccine presented by live-attenuated Salmonella typhimurium, Vaccine (2001) 19:2945–2954. [CrossRef] [PubMed]
  • Zhao L.J., Jian H., Zhu H., Specific gene inhibition by adenovirus-mediated expression of small interfering RNA, Gene (2003) 316:137–141. [CrossRef] [PubMed]
  • Zimmermann T.S., Lee A.C.H., Akinc A., Bramlage B., Bumcrot D., Fedoruk M.N., , RNAi-mediated gene silencing in non-human primates, Nature (2006) 441:111–114. [CrossRef] [PubMed]